NovoCure Ltd NVCR logo
NVCR

NovoCure Ltd

Company

CEO
Asaf Danziger
City
No 4 Grenville Street
State
Saint Helier
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Website
www.novocure.com
Description
more details

Key Statistics

Beta
1.85
Market Cap
7.51 B
Outstanding Shares
104,586,094
52 Week Low
56.39
52 Week High
188.94

News

Jul 20, 22 07:00 pm
GuruFocus - Top 5 2nd Quarter Trades of NORTHSTAR ASSET MANAGEMENT LLC

Jul 09, 22 03:00 pm
Stocks Register - NovoCure Limited (NASDAQ:NVCR) Shares In 2022: Bullish Prospects

Jul 01, 22 12:00 pm
Business Wire - Novocure to Report Second Quarter 2022 Financial Results

Jun 21, 22 09:38 pm
Benzinga - Recap of Tuesday''s Biotech Catalysts - End of the Day Summary

Jun 21, 22 12:00 pm
Business Wire - Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer

Jun 21, 22 12:00 pm
Wallstreet:Online - Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA for Patients with First-Line Stage III Non-Small Cell Lung Cancer

Jun 17, 22 12:00 am
Kwhen Finance - NovoCure Ltd Shares Close the Week 20.8% Lower - Weekly Wrap

Jun 16, 22 08:25 pm
The Motley Fool - Why Novocure Stock Is Plunging This Week

About

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure's commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.

Current Funds

Fund Company Shares Market Value Weight Ownership

Fund Holdings History

Date Ticker Fund Ticker Company Shares Market
Value 		Weight
2022-07-26 NVCR CTRU NOVOCURE LTD 1,600 114,192.00 0.96
2022-07-25 NVCR CTRU NOVOCURE LTD 1,600 114,880.00 0.96
2022-07-22 NVCR CTRU NOVOCURE LTD 1,600 120,384.00 0.98
2022-07-21 NVCR CTRU NOVOCURE LTD 1,600 120,928.00 1.00
2022-07-20 NVCR CTRU NOVOCURE LTD 1,688 124,354.96 1.00
2022-07-19 NVCR CTRU NOVOCURE LTD 1,688 121,316.56 1.01
2022-07-18 NVCR CTRU NOVOCURE LTD 1,688 122,312.48 1.02
2022-07-15 NVCR CTRU NOVOCURE LTD 1,688 122,970.80 1.04
2022-07-14 NVCR CTRU NOVOCURE LTD 1,688 123,190.24 1.03
2022-07-13 NVCR CTRU NOVOCURE LTD 1,864 134,655.36 1.02
2022-07-12 NVCR CTRU NOVOCURE LTD 1,864 135,736.48 1.01
2022-07-11 NVCR CTRU NOVOCURE LTD 1,864 138,718.88 1.01
2022-07-08 NVCR CTRU NOVOCURE LTD 1,864 140,284.64 1.02
2022-07-07 NVCR CTRU NOVOCURE LTD 1,864 137,656.40 1.03
2022-07-06 NVCR CTRU NOVOCURE LTD 1,864 138,905.28 1.03
2022-07-05 NVCR CTRU NOVOCURE LTD 1,864 136,631.20 1.04
2022-07-01 NVCR CTRU NOVOCURE LTD 1,864 129,548.00 0.99
5 Day
-0.91%
1 Month
-5.03%
3 Month
-9.35%
YTD
-4.37%
6 Month
4.15%
1 Year
-62.08%
2 Year
7.16%
5 Year
277.89%
NVCR Chart by TradingView